Strong methods. Reliable outcomes.
Sciom has extensive experience in developing analytical test methods for a wide range of pharmaceutical products in accordance with international regulatory requirements. We support the complete analytical method development process, from initial project planning and protocol preparation to method execution and comprehensive reporting, ensuring the methods are robust, reliable, and suitable for regulatory submission.
Discuss Your Analytical RequirementsDesigned. Tested. Perfected.
Each project begins with a clear definition of the analytical objective and scope for the QC method.The team specifies what needs to be measured (assay, related substances, dissolution, content uniformity, identification), the sample matrix, and the required working range.Target performance criteria are agreed upfront, including accuracy, precision, specificity, sensitivity, robustness, and applicable regulatory or pharmacopoeial expectations.
A thorough knowledge-gathering phase follows, reviewing pharmacopoeial methods, internal or legacy procedures, and scientific literature for similar products. Physicochemical properties of the analyte and key excipients (solubility, pKa, stability, degradation pathways) are evaluated in detail. This understanding shapes the analytical strategy and highlights potential interferences early.
Based on the defined objective and analyte characteristics, the most suitable analytical technique (HPLC/UPLC, GC, UV/Vis, FTIR, titration, etc.) is selected. These choices are translated into practical starting conditions such as column chemistry, mobile phase, detection settings, and sample preparation. From the outset, conditions are designed to be safe, cost-effective, and compatible with routine QC workflows.
The method is built and refined through structured scouting experiments to confirm detectability of analytes and major impurities or degradants. Critical parameters (pH, organic ratio, gradient, temperature, flow, injection volume) are systematically optimized to deliver robust separation, good peak shape, and efficient run times. Specificity, solution stability, and sample stability are evaluated under realistic laboratory conditions.
A focused pre-validation step confirms that the developed method can reasonably meet full validation requirements. Preliminary linearity, precision, and sensitivity are assessed alongside chromatographic indicators such as resolution, tailing factor, and plate count. Any necessary fine-tuning is performed to balance robustness, simplicity, and throughput for routine QC use. .
Clear system suitability criteria are established, including resolution between critical peaks, theoretical plates, tailing factor, and %RSD for replicate standards. Routine controls such as blanks, system suitability solutions, standard injection frequency, and QC check samples are defined. Sample preparation and handling procedures are crafted to be straightforward, reproducible, and compliant with safety and quality expectations
The method undergoes full validation in line with ICH guidelines and site procedures. Refer to the Analytical Method validation page.
Built to meet standards. Ready to perform.
Analytical methods are designed, validated, and documented in line with current regulatory guidelines, supporting smooth regulatory submissions, inspections, and ongoing compliance.
Regulatory alignment with applicable guidelines
Quality by Design (QbD) implementation
Lifecycle management and continuous improvement
Technology transfer between R&D and quality control (QC)
Reduction of out-of-specification (OOS) and out-of-trend (OOT) results
Control of critical quality attributes (CQAs)
Process understanding and risk mitigation
Inspection readiness and audit support
Cost-effective and efficient QC operations
Deep science. Real solutions.
Our method development team brings extensive experience across HPLC/UPLC, GC, LC/MS, GC/MS, dissolution, spectroscopy, and complex sample preparation to address a wide range of analytical challenges. A structured, QbD-driven approach is applied throughout, from impurity profiling and stability-indicating methods to trace-level quantification, ensuring methods remain scientifically sound, reliable, and suitable for transfer across laboratories while aligning with regulatory expectations.
Deep experience across HPLC/UPLC, GC, LC-MS, and GC-MS for complex products, impurities, and trace-level quantification
Advanced sample preparation strategies for challenging matrices, degradants, and low-level analytes
Structured, QbD-based development from scouting to robust, validated, and transfer-ready methods.
Methods engineered for routine QC: practical run times, clear system suitability, and inspection-ready documentation
Methods you can trust.
Sciom provides end-to-end analytical method development that is scientifically rigorous, regulatory-aligned, and genuinely QC-friendly. Methods are designed not only to pass validation, but to run reliably in real laboratories, across products, sites, and inspectors
Everything you need. One trusted partner.
Stay informed with expert commentary on pharmacovigilance services, regulatory consulting services, analytical science and audit compliance services across the pharmaceutical industry.